Skip to main navigation
Decibel Therapeutics logo
Menu Button

Top Menu

  • JOIN US
  • CONTACT US

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Patients & Families
    • Genetic Testing
    • Patients and Families
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us

SEC Filings

Filing date Form Description View
August 10, 2022 424B5

Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3

0001193125-22-217434.pdf
0001193125-22-217434.rtf
View HTML
August 10, 2022 8-K

Report of unscheduled material events or corporate event

0001193125-22-217451.pdf
0001193125-22-217451.rtf
0001193125-22-217451.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 28, 2022 8-K

Report of unscheduled material events or corporate event

0001193125-22-183295.pdf
0001193125-22-183295.rtf
0001193125-22-183295.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
June 21, 2022 4

Statement of changes in beneficial ownership of securities

0000899243-22-023459.pdf
0000899243-22-023459.rtf
0000899243-22-023459.xls
View HTML
June 21, 2022 4

Statement of changes in beneficial ownership of securities

0000899243-22-023465.pdf
0000899243-22-023465.rtf
0000899243-22-023465.xls
View HTML
June 21, 2022 4

Statement of changes in beneficial ownership of securities

0000899243-22-023470.pdf
0000899243-22-023470.rtf
0000899243-22-023470.xls
View HTML
June 21, 2022 4

Statement of changes in beneficial ownership of securities

0000899243-22-023469.pdf
0000899243-22-023469.rtf
0000899243-22-023469.xls
View HTML
June 21, 2022 4

Statement of changes in beneficial ownership of securities

0000899243-22-023471.pdf
0000899243-22-023471.rtf
0000899243-22-023471.xls
View HTML
June 17, 2022 8-K

Report of unscheduled material events or corporate event

0000950170-22-011802.pdf
0000950170-22-011802.rtf
0000950170-22-011802.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
May 17, 2022 EFFECT

EFFECT

9999999995-22-001508.pdf
9999999995-22-001508.rtf
9999999995-22-001508.xls
View HTML

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »
Displaying 11 - 20 of 119 results

Data provided by Kaleidoscope.

Shareholder Tools

Contact IR
Contact IR
Email Alerts
Email Alerts
Print Page
Print Page
RSS Feeds
RSS Feeds
Search
Search

© Decibel Therapeutics, Inc. 2023. All rights reserved.

  • Privacy Notice
  • Terms of Use
  • Twitter
  • LinkedIn

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Patients & Families
    • Genetic Testing
    • Patients and Families
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us